The dosage by the outpatient going to hospital is possible to administer it by the intravenous feeding for around 30 minutes once a week, and, in the case of gemushitabin (Cem Saar) which is the anticancer agent which is generally used as a standard therapeutic drug for pancreatic cancer (pancreatic cancer) now, the dosage method that medicine does once afterwards on a holiday if you continue it for three weeks and administer it is usually performed basically.
As a side effect by the anticancer agent dosage with gemushitabin (Cem Saar), there seem to be nausea and inappetence like other anticancer agent.
Even if thrombocytic decrease to be related to solidification of a white blood corpuscle and the blood related to an immunity function is seen, other than a side effect such as nausea and the inappetence, you are said to be it, and there seems to be it when influence such as the aggravation of the liver numerical value, the myeloablation produces it.
You perform a blood test before administering gemushitabin (Cem Saar) and seem to usually decide judgment of the dosage the onset condition of the side effect is a patient individual individual, and to be different after watching the degree of the side effect.
